drugset / Trial / NCT03318484
Sonodynamic Therapy on Patients With Femoropopliteal PAD and Claudication
Phase 1/2
Withdrawn
First Affiliated Hospital of Harbin Medical University
Harbin Medical University · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this trial is to evaluate the safety and efficacy of sonodynamic therapy (SDT) in reducing atherosclerotic plaques inflammation and increasing peak walking time (PWT) among peripheral artery disease (PAD) patients with symptom of intermittent claudication.
Timeline
- Start
- 2017-11
- Primary completion
- 2019-11
- Completion
- 2019-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sinoporphyrin sodium | Other / unclassified | 0.2 mg/kg | Intravenous |
| Background | Aspirin | Small molecule | 100 mg | — |
| Background | Atorvastatin | Small molecule | 20 mg | — |